Treatment-induced leukoencephalopathy in primary CNS lymphoma: A clinical and autopsy study

Neurology

Volumn 62, Issue 3, 2004, Pages 451-456

  Lai, Rose ^a   Abrey, Lauren E ^a   Rosenblum, Marc K ^a   DeAngelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; MYELIN;

ADULT; AGED; ATHEROSCLEROSIS; AUTOPSY; BRAIN CIRCULUS ARTERIOSUS; BRAIN SPONGIOSIS; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM LYMPHOMA; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DATA BASE; DIFFUSION WEIGHTED IMAGING; DRUG MEGADOSE; FEMALE; GLIOSIS; HUMAN; LEUKOENCEPHALOPATHY; MALE; MEDICAL RECORD; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STROKE; TISSUE NECROSIS; VASCULAR DISEASE; WHITE MATTER;

EID: 1042288159     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000106941.51340.A2     Document Type: Review

References (33)

1. DeAngelis LM. Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol 1999;43:249-257.
2. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000;18:3144-3150.
3. Vigliani MC, Duyckaerts C, Hauw JJ, et al. Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study. J Neurooncol 1999;41:137-149.
4. Asai A, Matsutani M, Kohno T, et al. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 1989;63:1962-1974.
5. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-796.
6. Poisson M, Hauw JJ, Mashalay R, et al. Status spongiosus in the course of treatment of malignant gliomas. J Neurooncol 1983;1:29-37.
7. Lai R, Rosenblum MK, DeAngelis LM. Primary central nervous system lymphoma: a whole brain disease? Neurology 2002;59:1557-1562.
8. Kastenbauer S, Wiesmann M, Pfister HW. Cerebral vasculopathy and multiple infarctions in a woman with carcinomatous meningitis while on treatment with intrathecal methotrexate. J Neurooncol 2000;48:41-45.
9. Follezou JY, Chauveinc L, Guerin JM. Cerebral arterial disturbances in a transient encephalopathy induced by methotrexate. Med Oncol Tumor Pharmacother 1993;10:181-183.
10. Marks JE, Wong J. The risk of cerebral radionecrosis in relation to dose, time and fractionation: a follow-up study. Prog Exp Tumor Res 1985;29:210-218.
11. Wilkinson HA, Fujiwara T, Rosenfeld S. Synergistic effect between intraneoplastic methotrexate and radiation on experimental intracerebral rat gliosarcoma. Neurosurgery 1994;34:665-668.
12. Bezek S, Trnovec T, Scasnar V, et al. Irradiation of the head by 60Co opens the blood-brain barrier for drugs in rats. Experientia 1990;46: 1017-1020.
13. d'Avella D, Cicciarello R, Angileri FF, et al. Radiation-induced blood-brain barrier changes: pathophysiological mechanisms and clinical implications. Acta Neurochir suppl (Wien) 1998;71:282-284.
14. Rubin P, Gash DM, Hansen JT, Nelson DF, Williams JP. Disruption of the blood-brain barrier as the primary effect of CNS irradiation. Radiother Oncol 1994;31:51-60.
15. Krueck WG, Schmiedl UP, Maravilla KR, et al. MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model. Am J Neuroradiol 1994;15:625-632.
16. Delattre JY, Shapiro WR, Posner JB. Acute effects of low-dose cranial irradiation on regional capillary permeability in experimental brain tumors. J Neurol Sci 1989;90:147-153.
17. Spence AM, Graham MM, O'Gorman LA, et al. Regional blood-to-tissue transport in an irradiated rat glioma model. Radiat Res 1987;111:225-236.
18. Qin DX, Zhen R, Tanj J, Li JX, Hu YH. Influence of radiation on the blood-brain barrier and optimum time of chemotherapy. Int J Radiat Oncol Biol Phys 1990;19:1507-1510.
19. van Vulpen M, Kal HB, Taphoorn MJ, El-Sharouni SY. Changes in blood-brain permeability induced by radiotherapy: implications for timing of chemotherapy? Oncol Rep 2002;9:683-688.
20. DeAngelis LM. Cerebral lymphoma presenting as a non-enhancing lesion on computed tomographic/magnetic resonance scan. Ann Neurol 1993;33:308-311.
21. Imperato JR, Paleogogos NA, Vick NA. Effects of treatment on long-term survivors with malignant gliomas. Ann Neurol 1990;28:818-822.
22. Maher CO, Raffel C. Early vasculopathy following radiation in a child with medulloblastoma. Pediatr Neurosurg 2000;32:255-258.
23. Jamjoom AB, Malabarey T, Jamjoom ZA, et al. Cerebro-vasculopathy and malignancy: catastrophic complications of radiotherapy for optic nerve glioma in a von Recklinghausen neurofibromatosis patient. Neurosurg Rev 1996;19:47-51.
24. Bowen J, Paulsen CA. Stroke after pituitary irradiation. Stroke 1992; 23:908-911.
25. Laitt RD, Chambers EJ, Goddard PR, et al. Magnetic resonance imaging and magnetic resonance angiography in long term survivors of acute lymphoblastic leukemia treated with cranial irradiation. Cancer 1995;76:1846-1852.
26. Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995;26:131-136.
27. Fouladi M, Langston J, Mulhern R, et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol 2000;18:824-831.
28. Omura M, Aida N, Sekido K, et al. Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997;38:241-249.
29. Brant-Zawadzki M, Anderson M, DeArmond SJ, et al. Radiation-induced large intracranial vessel occlusive vasculopathy. Am J Roentgenol 1980;134:51-55.
30. Molnar PP, O'Neill BP, Scheithauer BW, et al. The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death. Neurooncol 1999;1:89-100.
31. Sacco RL. Newer risk factors for stroke. Neurology 2001;57(suppl 2): S31-34.
32. Quinn CT, Griener JC, Bottiglieri T, et al. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol 1997;15:2800-2806.
33. Vezmar S, Becker A, Bode U, et al. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 2003;49:92-104.